Please ensure Javascript is enabled for purposes of website accessibility

Why MiMedx Group, Core Laboratories, and Nordstrom Slumped Today

By Steve Symington - Jul 2, 2018 at 4:42PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out which of these companies just replaced multiple high-level executives.

Stocks stayed in the green on Monday, bouncing back from sharp losses early in the session as investors awaited awaited a decision from President Trump on whether to impose new trade tariffs on China later this week. 

But several individual companies bucked the indexes' trend. Read on to learn why MiMedx Group (MDXG -3.09%), Core Laboratories (CLB 0.54%), and Nordstrom (JWN -3.59%) trailed the broader market today.

Stock market prices with red and green arrows indicating direction

Image source: Getty Images.

MiMedx's executive turnover

Shares of MiMedx Group plummeted 38.5% after the biopharmaceutical company announced a slew of executive leadership and business changes amid the ongoing investigation into its business practices. Pete Petit has resigned as My MiMedx's chairman and CEO -- though he remains a director on the company's board -- while Chief Operating Officer and board member Bill Taylor simultaneously resigned from both of his respective roles.

The company further unveiled a number of initiatives to "promote accountability and strengthen oversight," including a newly formed ethics and compliance committee, new chief accounting officer and internal auditor positions, and a review of its Sarbanes-Oxley and other internal control policies.

Finally, MiMedx confirmed that would need to restate its previously issued financial statements for fiscal years 2012 through 2016, as well as for the first three quarters of 2017. MiMedx also continues to cooperate with investigations being performed by the SEC and U.S. Department of Justice.

Of course, these changes are almost certainly for the better, and MiMedx is doing its best to continue focusing on executing its business strategy. But it shouldn't come as a surprise to see more investors heading for the exits today.

Core Labs' reduced guidance

Core Laboratories stock fell 10.7% after the oil-services specialist reduced its second-quarter outlook following delays in the recovery of international field development activity for its reservoir description segment. Core Labs now expects second-quarter 2018 revenue will range from $174 million to $175 million -- up only slightly from its seasonally slow first quarter -- which should translate to earnings per share of $0.57 to $0.59.

If that wasn't enough, Core Labs predicted its third-quarter results will likely be similar to its previous second-quarter guidance, which called for revenue of between $177 million and $179 million, and earnings per share of $0.64 to $0.66. Both ranges were well below consensus estimates for third-quarter earnings of $0.74 per share on revenue of $187 million. 

Nordstrom goes out of style on Wall Street

Finally, after falling more than 5% early in the day, shares of Nordstrom ultimately closed down 2.1% after Cowen analyst Oliver Chen downgraded the department store chain. 

Chen reduced his firm's rating on Nordstrom stock from outperform to market perform and lowered his per-share price target from $56 to $51. To justify his relative bearishness, Chen noted that same-store sales at Nordstrom Rack -- the chain's off-price division -- have fallen for the past year and a half, bolstered only by strength in digital sales. Chen also worries that Nordstrom will need to close additional underperforming physical locations over the long term.

Given this tempered enthusiasm, it's hard to blame some investors for taking a step back from Nordstrom today.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Core Laboratories N.V. Stock Quote
Core Laboratories N.V.
$26.02 (0.54%) $0.14
Nordstrom, Inc. Stock Quote
Nordstrom, Inc.
$20.68 (-3.59%) $0.77
MiMedx Group, Inc. Stock Quote
MiMedx Group, Inc.
$3.45 (-3.09%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.